Uncovering Phenotypical Features of Narcolepsy Type 1
Episode 98, Sep 22, 2023, 10:00 AM
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, Birgitte R. Kornum, MD, an associate professor in the department of neuroscience at the University of Copenhagen, discussed recently published preclinical research assessing phenotypical features and disease progression of narcolepsy type 1. Kornum provided insight on the 2 mouse models used, the effectiveness of the DVC System, and some of the phenotypic features identified. In addition, she gave insight on how the research adds to the ongoing puzzle of treating narcolepsy and where future efforts should be directed toward.
Looking for more movement disorder discussion? Check out the NeurologyLive® Narcolepsy clinical focus page.
Episode Breakdown:
In this episode, Birgitte R. Kornum, MD, an associate professor in the department of neuroscience at the University of Copenhagen, discussed recently published preclinical research assessing phenotypical features and disease progression of narcolepsy type 1. Kornum provided insight on the 2 mouse models used, the effectiveness of the DVC System, and some of the phenotypic features identified. In addition, she gave insight on how the research adds to the ongoing puzzle of treating narcolepsy and where future efforts should be directed toward.
Looking for more movement disorder discussion? Check out the NeurologyLive® Narcolepsy clinical focus page.
Episode Breakdown:
- 1:15 – Overview of Medicare study and objectives
- 3:15 – Advantages of DVC System
- 5:40 – Clinical takeaways from the findings
- 9:30 – Neurology News Minute
- 12:05 – Critical phenotypic features of narcolepsy
- 14:20 – Significance of this research, future goals
This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Alzheimer Agent ALZ-801 Improves Cognition, Reduces Relevant Biomarker Levels in 2-Year Analysis
FDA Updates Label for Psychosis Medication Pimavanserin
FDA Approves AI-Incorporated Alzheimer Detection Software AIRAscore
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.